Anelixis Therapeutics

United States
Primghar, Iowa, United States, 02130

Company profile

Anelixis Therapeutics company profile

Anelixis Therapeutics is a clinical stage development company located in Cambridge, Massachusetts with a portfolio focused on immune modulatory drugs for neurodegenerative diseases with a focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD). Anelixis Therapeutics is committed to advancing treatments that will have a meaningful impact on the lives of patients by helping them battle back their disease progression.

Business identity

Phone number
+1.617.599.6514
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2012-01-01, Year

Headquarters

Postal code
02130
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$6.9M
Last funding
Series Unknown / $2.6M / 2018-04-25
Last equity funding
Series Unknown / $2.6M
Founders
1
Articles
6
Exited on
2020-09-14

Founders and investors

Founders

Steve Perrin